These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4899216)

  • 1. [Tuberculosis vaccination--knowledge, experience and perspectives].
    Ganguin HG; Mydlak G; Zureck A
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(1):101-39. PubMed ID: 4899216
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):436-43. PubMed ID: 812905
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of the study of the W 115 M. tuberculosis vaccine strain and the lyophilized experimental vaccine W 115.
    Weiszfeiler JG
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):492-7. PubMed ID: 812909
    [No Abstract]   [Full Text] [Related]  

  • 4. A quarter of a century in the field of BCG.
    Rodopska S
    Dev Biol Stand; 1986; 58 ( Pt A)():257-72. PubMed ID: 3297865
    [No Abstract]   [Full Text] [Related]  

  • 5. Historical review of BCG vaccine in Japan.
    Yamamoto S; Yamamoto T
    Jpn J Infect Dis; 2007 Nov; 60(6):331-6. PubMed ID: 18032829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [30 Years of BCG-vaccination in GDR - 30 years of BCG-vaccine production in Jena].
    Zureck A
    Z Erkr Atmungsorgane; 1982; 158(1-2):168-84. PubMed ID: 7041443
    [No Abstract]   [Full Text] [Related]  

  • 7. [BCG vaccination].
    Hutás I
    Orv Hetil; 1996 Mar; 137(12):619-22. PubMed ID: 8901354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination-related Mycobacterium bovis BCG infection.
    Liberek A; Korzon M; Bernatowska E; Kurenko-Deptuch M; Rytlewska M
    Emerg Infect Dis; 2006 May; 12(5):860-2. PubMed ID: 16710956
    [No Abstract]   [Full Text] [Related]  

  • 9. What is BCG?
    Grange JM; Gibson J; Osborn TW; Collins CH; Yates MD
    Tubercle; 1983 Jun; 64(2):129-39. PubMed ID: 6412409
    [No Abstract]   [Full Text] [Related]  

  • 10. [BCG: substrains, the vaccine, vaccination].
    Balazs ED
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(3):117-24. PubMed ID: 9417279
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of acid-fast organisms isolated from tuberculous lymphadenitis-lesion of two children who had been BCG-vaccinated. Differentiation of BCG from other strains of Mycobacterium bovis].
    Tsukamura M; Shoji R; Matsuda K
    Kekkaku; 1984 Apr; 59(4):289-93. PubMed ID: 6379259
    [No Abstract]   [Full Text] [Related]  

  • 12. Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications.
    Torres-Rojas JR; Rondón-Lugo A; Vidal R
    Dermatol Online J; 2002 Oct; 8(2):6. PubMed ID: 12546761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the BCG vaccination in Hungary since 1929: evaluation of preventive and immunotherapeutic effectiveness].
    Lugosi L
    Orv Hetil; 1998 Jun; 139(26):1563-70. PubMed ID: 9676117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín.
    Palmer MV; Thacker TC; Waters WR
    Vaccine; 2007 Sep; 25(36):6589-97. PubMed ID: 17688976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterium bovis dissemination after BCG administration to a 6-year-old child. Multiple cutaneous, ossous and lymph node lesions. Recovery].
    Sacrez R; Levy M; Reys P; Kirsch W; Lahlou B
    Pediatrie; 1967 Jun; 22(4):435-45. PubMed ID: 4884539
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J; O'Connor ME
    Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM; Islam ST; Ren H; Liu J
    Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [History of anti-tuberculosis vaccination and the development of BCG vaccine].
    Moskwa Z
    Wiad Lek; 1983 Jan; 36(1):81-5. PubMed ID: 6342271
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated BCG disease and the full contraindication to BCG vaccination for children exposed to and/or infected by HIV.
    Fernandes RC; Medina-Acosta E
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1188-9; author reply 1189-90. PubMed ID: 19723415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.